Lido Advisors »

Chemomab Therapeutics shares owned by Lido Advisors

Quarter-by-quarter ownership of Chemomab Therapeutics (CMMB) shares owned by Lido Advisors from 13F filings

Historical chart of Lido Advisors investment in Chemomab Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Chemomab Therapeutics held by Lido Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Chemomab Therapeutics by Lido Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $23k 14k 1.62

More positions owned by Lido Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Apple Put Option (AAPL)
NVIDIA Corporation Put Option (NVDA)
Invesco Exch Trd Slf Idx Bulshs 2027 Cb (BSCR)
Invesco Exch Trd Slf Idx Bulshs 2026 Cb (BSCQ)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Fidelity Covington Trust Msci Info Tech I (FTEC)
Ssga Active Tr State Street My (MYCH)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr S&p 500 Val Etf (IVE)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Micron Technology (MU)
Broadcom Put Option (AVGO)

View all positions for Lido Advisors

Top funds holding Chemomab Therapeutics

Citadel Advisors
ADAR1 Capital Management
Kestra Private Wealth Services
Ikarian Capital
Rhumbline Advisers
XTX Topco
Lido Advisors
Philadelphia Investment Partners
Bnp Paribas Arbitrage, Snc
GAMMA Investing
Morgan Stanley
SBI Securities
Caitong International Asset Management

View all funds holding Chemomab Therapeutics